Browse > Article

The Adequate Induction Dose of Propofol for Conscious Sedation During Esophagogastroduodenoscopy in Persons 60 Years or Older  

Moon, Hyeung-Cheol (Department of Internal Medicine, Kwangju Christian Hospital)
Hong, Gun-Young (Department of Internal Medicine, Kwangju Christian Hospital)
Kim, Du-Jin (Department of Internal Medicine, Kwangju Christian Hospital)
Choi, Sang-Chul (Department of Internal Medicine, Kwangju Christian Hospital)
Park, Sang-Wook (Department of Internal Medicine, Kwangju Christian Hospital)
Lim, Yeun-Keun (Department of Internal Medicine, Kwangju Christian Hospital)
Publication Information
Clinical Endoscopy / v.41, no.3, 2010 , pp. 134-139 More about this Journal
Abstract
Background/Aims: Propofol is an effective sedative drug in endoscopic procedures, but it has potentially serious adverse effects, so close monitoring of the vital signs should be performed during endoscopy. This study was undertaken to determine the adequate induction dose of propofol for safe and effective sedation during esophagogastrodudenoscopy (EGD) in persons 60 years or older. Methods: Three hundred patients who visited our hospital for EGD were randomly assigned to three groups (A,B and C). An initial induction dose of 0.5 mg/kg, 0.75 mg/kg and 1.0 mg/kg of propofol was allocated to groups A, B and C, respectively. Results: The 0.5 mg/kg, 0.75 mg/kg and, 1 mg/kg dose of propofol were all safe as an initial dose of propofol for achieving sedation during EGD in persons 60 years or older. There was no difference in the total amount of propofol among the three groups. Group C had a significantly shorter induction time and a lower dose was required for an additional injection of propofol without increasing adverse events, as compared to the two other groups. Conclusions: We suggest that 1 mg/kg of propofol is an effective induction dose for sedation during EGD in persons 60 years or older.
Keywords
Propofol; Endoscopy; Gastrointestinal; Aged;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Searle NR, Sahab P. Propofol in patients with cardiac disease. Can J Anaesth 1993;40:730-747.   DOI   ScienceOn
2 Heuss LT, Schnieper P, Drewe J, Pflimlin E, Beglinger C. Risk stratification and safe administration of propofol by registered nurses supervised by the gastroenterologist: a prospective observational study of more than 2000 cases. Gastrointest Endosc 2003;57:664-671.   DOI   ScienceOn
3 Na IG, Jo JD, Chung SR, et al. Propofol as premedication for upper gastrointestinal endoscopy. Korean J Gastrointest Endosc 2000;20:165-170.
4 Choi WH, Kim SW, Lee YS, et al. The effect of upper gastrointestinal endoscopy using conscious sedation with propofol. Korean J Med 2003;64:509-515.
5 Cummings GC, Dixon J, Kay NH, et al. Dose requirement of ICI 35868 (propofol, 'Dipirivan') in a new formulation for induction of anaesthesia. Anaesthesia 1984;39:1168-1171.   DOI   ScienceOn
6 Standards of Practice Committee of American Society for Gastrointestinal Endoscopy, Lichtenstein DR, Jagannath S, Baron TH, et al. Sedation and anesthesia in GI endoscopy. Gastrointest Endosc 2008;68:815-826.   DOI   ScienceOn
7 Oei-Lim VL, Kalkman CJ, Bartelsman JF, Res JC, van Wezel HB. Cardiovascular response, arterial oxygen saturation and plasma catecholamine concent-ration during upper gastrointestinal endoscopy using conscious sedation with midazolam or propofol. Eur J Anaesth 1998;15:535-543.   DOI   ScienceOn
8 Kerker A, Hardt C, Schlief HE, Dumoulin FL. Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patients. BMC Gastroenterology 2010;10:11.   DOI   ScienceOn
9 Training Committee. American Society for Gastrointestinal Endoscopy. Training guideline for use of propofol in gastrointestinal endoscopy. Gastrointest Endosc 2004;60:167-172.   DOI   ScienceOn
10 Carlsson U, Grattidge P. Sedation for upper gastrointestinal endoscopy: a comparative study of propofol and midazolam. Endoscopy 1995;27:240-243.   DOI   ScienceOn
11 Fleisher D. Monitoring the patient receiving conscious sedation for gastrointestinal endoscopy: issues and guidelines. Gastrointest Endosc 1989;35:262-266.   DOI   ScienceOn
12 Steib A, Freys G, Beller JP, Curzola U, Otteni JC. Propofol in elderly high risk patients. A comparison of hemodynamic effects with thiopentone during induction of anaesthesia. Anaesthesia 1988;43(suppl):111S-114S.   DOI
13 Wehrmann T. Kokabpick S, Lembcke B, Caspray WF, Seifert H. Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study. Gastrointest Endosc 1999;49:677-683.   DOI   ScienceOn
14 Oei-Lim VLB, Kalkman CJ, Bartelsman JF, Res JCJ, van Wezel HB. Cardiovascular response, arterial oxygen saturation and plasma catecholamine concentration during upper gastrointestinal endoscopy using conscious sedation with mida-zolam or propofol. Eur J Anaesth 1998;15:535-543.   DOI   ScienceOn
15 Patterson KW, Casey PB, Murray JP, O'Boyle CA, Cunning-Ham AJ. Propofol sedation for outpatient upper gastrointestinal endoscopy: comparison with midazolam. Br J Anaesth 1991;67:108-111.   DOI   ScienceOn
16 Hong GY, Seo KS, Park SW, Moon HC, Choi SC, Lim YK. The adequate dose of propofol for inducing sedation during performance of upper gastrointestinal endoscopy in Koreans. Korean J Gastrointest Endosc 2009;39:66-71.
17 Lieberman DA, Wuerker CK, Katon RM. Cardiopulmonary risk of esophagogastroduodenoscopy: role of endoscope diameter and systemic sedation. Gastroenterology 1985;88:468-472.   DOI
18 Carter AS, Coady T, Bell GD, Lee J, Modern A. Monitoring during sedation for endoscopy. BMJ 1989;298:114.